Stimcell Energetics (STME) Income towards Parent Company (2016 - 2024)
Stimcell Energetics (STME) posted Income towards Parent Company of -$124957.0 for Q2 2024, down 85.0% on a QoQ basis from -$67546.0 in Q1 2024, and down 57.41% year-over-year from -$293397.1 in Q2 2023.
Powered by 
Analysis
Stimcell Energetics (STME) Income towards Parent Company (2016 - 2024) Analysis & Trends
Stimcell Energetics has reported Income towards Parent Company for 9 years, with the latest figure at -$124957.0 in Q2 2024.
- On a quarterly basis, Income towards Parent Company fell 57.41% year-over-year to -$124957.0 in Q2 2024; TTM through May 2024 was -$330003.0, a 33.34% increase from a year earlier, with the FY2024 full-year figure at -$330003.0, up 33.34% from the prior year.
- Income towards Parent Company was -$124957.0 for Q2 2024 at Stimcell Energetics, down from -$67546.0 in the prior quarter.
- The five-year high for Income towards Parent Company was -$60547.0 in Q4 2023, with the low at -$258815.0 in Q1 2020.
- Average Income towards Parent Company over 5 years is -$155013.6, with a median of -$158623.0 recorded in 2022.
- The largest YoY upside for Income towards Parent Company was 79.07% in 2020 against a maximum downside of 401.54% in 2020.
- Over 5 years, Income towards Parent Company stood at -$189336.0 in 2020, then increased by 7.06% to -$175977.0 in 2021, then rose by 18.85% to -$142813.0 in 2022, then soared by 57.6% to -$60547.0 in 2023, then plunged by 106.38% to -$124957.0 in 2024.
- The last three Income towards Parent Company figures came in at -$124957.0 (Q2 2024), -$67546.0 (Q1 2024), and -$60547.0 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 178.50 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.21 Bn | 118.99 Bn | 1.96 Bn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.39 Bn | 65.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.69 Bn | 45.43 Bn | 1.35 Bn |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 5.92 Mn | 5.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2024 | -124,957.00 |
| Feb 29, 2024 | -67,546.00 |
| Nov 30, 2023 | -60,547.00 |
| Aug 31, 2023 | -76,953.00 |
| May 31, 2023 | -79,383.00 |
| Feb 28, 2023 | -118,161.00 |
| Nov 30, 2022 | -142,813.00 |
| Aug 31, 2022 | -154,685.00 |
| May 31, 2022 | -162,561.00 |
| Feb 28, 2022 | -119,489.00 |
| Nov 30, 2021 | -175,977.00 |
| Aug 31, 2021 | -239,352.00 |
| May 31, 2021 | -187,629.00 |
| Feb 28, 2021 | -179,008.00 |
| Nov 30, 2020 | -189,336.00 |
| Aug 31, 2020 | -201,202.00 |
| May 31, 2020 | -251,830.00 |
| Feb 29, 2020 | -258,815.00 |
| Nov 30, 2019 | -303,488.00 |
| Aug 31, 2019 | -245,287.00 |